144 related articles for article (PubMed ID: 38146232)
21. Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET).
Body A; Ahern E; Lal L; Gillett K; Abdulla H; Opat S; O'Brien T; Downie P; Turville S; Munier CML; Smith C; MacIntyre CR; Segelov E
BMC Infect Dis; 2022 Jan; 22(1):70. PubMed ID: 35057745
[TBL] [Abstract][Full Text] [Related]
22. CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 Pandemic.
Parsonage WA; Cullen L; Brieger D; Hillis GS; Nasis A; Dwyer N; Wahi S; Lo S; Than M; Kerr A; Devlin G; Chew DK
Heart Lung Circ; 2020 Jul; 29(7):e105-e110. PubMed ID: 32601022
[TBL] [Abstract][Full Text] [Related]
23. Chronic lymphocytic leukaemia Australasian consensus practice statement.
Anderson MA; Bennett R; Badoux X; Best G; Chia N; Cochrane T; Cull G; Crassini K; Harrup R; Jackson S; Kuss B; Lasica M; Lew TE; Marlton P; Opat S; Palfreyman E; Polizzotto MN; Ratnasingam S; Seymour JF; Soosapilla A; Talaulikar D; Tam CS; Weinkove R; Wight J; Mulligan SP
Intern Med J; 2023 Sep; 53(9):1678-1691. PubMed ID: 37743239
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement.
Doyle J; Raggatt M; Slavin M; McLachlan SA; Strasser SI; Sasadeusz JJ; Howell J; Hajkowicz K; Nandurkar H; Johnston A; Bak N; Thompson AJ
Med J Aust; 2019 Jun; 210(10):462-468. PubMed ID: 31104328
[TBL] [Abstract][Full Text] [Related]
25. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches.
Kakavandi S; Hajikhani B; Azizi P; Aziziyan F; Nabi-Afjadi M; Farani MR; Zalpoor H; Azarian M; Saadi MI; Gharesi-Fard B; Terpos E; Zare I; Motamedifar M
Cell Commun Signal; 2024 Feb; 22(1):126. PubMed ID: 38360719
[TBL] [Abstract][Full Text] [Related]
26. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
Gupta A; Desai N; Sanjeev ; Chauhan P; Nityanand S; Hashim Z; Gupta M
Ann Hematol; 2022 Jan; 101(1):69-79. PubMed ID: 34559278
[TBL] [Abstract][Full Text] [Related]
27. Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2.
Wang J; Shao L; Liang J; Wu Q; Zhu B; Deng Q; Liu Z; Liu L; Wang D; Yu Z; Tan X; Wang F; Meng J; Xu X; Xia Z; Li Z; Wang H; Wang L; Wu W; Xie Q; Huang X; Sun Z; Zhang Y; Zhou H; Zhou H; Yang W; Ren H; Liu Z; Qiao M; Tang F; Qi X; Wu H; Deng L; Gao L; Zhang H; Chen P; Zhang H; Zhang X; Zhou J; Chuanqing TU; Guan L; Yin Q; Shu R; Chen F; He M; Wang Q; Guo Z; ;
J Cancer Res Ther; 2023 Dec; 19(6):1495-1500. PubMed ID: 38156914
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 in patients with hematologic malignancy.
Langerbeins P; Hallek M
Blood; 2022 Jul; 140(3):236-252. PubMed ID: 35544585
[TBL] [Abstract][Full Text] [Related]
29. Systematic review and meta-analysis of the clinical effectiveness of tixagevimab/cilgavimab for prophylaxis of COVID-19 in immunocompromised patients.
Suribhatla R; Starkey T; Ionescu MC; Pagliuca A; Richter A; Lee LYW
Br J Haematol; 2023 Jun; 201(5):813-823. PubMed ID: 37006158
[TBL] [Abstract][Full Text] [Related]
30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
31. Mitigation of in-hospital risk of coronavirus disease 2019: Experience from a haematology-oncology and stem cell transplant setting.
Singh S; Paul D; Jain K; Singh J
Natl Med J India; 2021; 34(1):10-14. PubMed ID: 34396997
[TBL] [Abstract][Full Text] [Related]
32. Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
Aiello TF; Puerta-Alcalde P; Chumbita M; Lopera C; Monzó P; Cortes A; Fernández-Avilés F; Suárez-Lledó M; Correa J; Ortiz-Maldonado V; Cuesta G; Martinez-Cibrian N; Esteve J; Marcos MÁ; Mensa J; Soriano A; Garcia-Vidal C
J Antimicrob Chemother; 2023 Jun; 78(6):1454-1459. PubMed ID: 37051877
[TBL] [Abstract][Full Text] [Related]
33. Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV-2 pandemic.
Schalk E; Schmitt T; Panse J; Fiegle E; Naendrup JH; Schmidt-Hieber M; Böll B; Hentrich M; Teschner D; Mougiakakos D
Br J Haematol; 2022 Nov; 199(4):e16-e20. PubMed ID: 36017820
[No Abstract] [Full Text] [Related]
34. Impact of COVID 19 on red flag discussions for haematological malignancies within the Belfast trust.
Waddell D; Benson G
Ulster Med J; 2021 May; 90(2):77-80. PubMed ID: 34276084
[TBL] [Abstract][Full Text] [Related]
35. Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Giesen N; Sprute R; Rüthrich M; Khodamoradi Y; Mellinghoff SC; Beutel G; Lueck C; Koldehoff M; Hentrich M; Sandherr M; von Bergwelt-Baildon M; Wolf HH; Hirsch HH; Wörmann B; Cornely OA; Köhler P; Schalk E; von Lilienfeld-Toal M
Eur J Cancer; 2020 Nov; 140():86-104. PubMed ID: 33068941
[TBL] [Abstract][Full Text] [Related]
36. COVID-19 safety: aerosol-generating procedures and cardiothoracic surgery and anaesthesia - Australian and New Zealand consensus statement.
Irons JF; Pavey W; Bennetts JS; Granger E; Tutungi E; Almeida A
Med J Aust; 2021 Jan; 214(1):40-44. PubMed ID: 33040381
[TBL] [Abstract][Full Text] [Related]
37. Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
Hofsink Q; Haggenburg S; Lissenberg-Witte BI; Broers AEC; van Doesum JA; van Binnendijk RS; den Hartog G; Bhoekhan MS; Haverkate NJE; van Meerloo J; Burger JA; Bouhuijs JH; Smits GP; Wouters D; van Leeuwen EMM; Bontkes HJ; Kootstra NA; Vogels-Nooijen S; Rots N; van Beek J; Heemskerk MHM; Groen K; van Meerten T; Mutsaers PGNJ; van Gils MJ; Goorhuis A; Rutten CE; Hazenberg MD; Nijhof IS;
EClinicalMedicine; 2023 Jul; 61():102040. PubMed ID: 37337616
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 in children with haematological malignancies.
Millen GC; Arnold R; Cazier JB; Curley H; Feltbower R; Gamble A; Glaser A; Grundy RG; Kirton L; Lee LYW; McCabe MG; Palles C; Phillips B; Stiller CA; Varnai C; Kearns P
Arch Dis Child; 2022 Feb; 107(2):186-188. PubMed ID: 34301621
[TBL] [Abstract][Full Text] [Related]
39. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies.
Haggenburg S; Hofsink Q; Rutten CE; Nijhof IS; Hazenberg MD; Goorhuis A
Semin Hematol; 2022 Oct; 59(4):192-197. PubMed ID: 36805887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
